Home » Newsletters » BioWorld

BioWorld

Aug. 22, 2003

View Archived Issues

IPOs On The Rise: Nitromed, Pharmion, Acusphere On File

Three biotech companies recently have filed for initial public offerings in what appears to be a developing trend. (BioWorld Today) Read More

Cephalon's Hostile Takeover Bid For CIMA Ups The Ante

Two Human Immunities - Innate, Adaptive - Set Experimental Model To Mimic Multiple Sclerosis Course

Merck Options, Returns Aspects Of Vical's DNA Delivery Platform

BioStratum Opens Bridge Funding With $9.5M For Nephropathy Drug

CuraGen Subsidiary Sequences Whole Adenovirus In One Day

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...